On-Demand Event Recording - From Data to Patients: Accelerating Retina Clinical Trials with AI, Real-World Ev

Watch our on-demand program recording where leading clinical investigators and retinal specialists explore how AI-enabled solutions, large-scale ophthalmic data analysis, and real-world evidence (RWE) accelerate retina clinical development—from candidate identification and site selection to understanding disease progression and treatment outcomes.

Key Highlights

• Accelerate Candidate Identification: Transition beyond manual EHR searches into automated, phenotype-driven screening to identify eligible clinical trial candidates up to 5x faster.  
• Mine Large-Scale Real-World Datasets: Explore how mining multi-center RWE databases (such as the RIMR AMD Consortium) reveals real-world disease trajectories before designing clinical trials.  
• Connect Phenotypes to Endpoints: Discover how AI-driven structural biomarker segmentation and functional correlations inform exploratory and formal trial endpoints.  
• Scale Across Clinical Networks: Learn how multi-site networks (RAINET) turn distributed clinical and imaging data into consistent, actionable population-level evidence.

‍

Faculty (Speakers & Panelists)

• David Eichenbaum, MD, FASRS (Retina Vitreous Associates of Florida | EIRVERA) – Program Moderator & Presenter
• Michael Javaheri, MD, MSc, FASRS (Retina Specialists of Beverly Hills) – Presenter & Panelist
• Samuel Minaker, MD, MSc (Tyler Retina Consultants) – Presenter & Panelist
• Deepak Sambhara, MD, FASRS (Eye Clinic of Wisconsin) – Presenter & Panelist

‍

Program Sessions & Discussions

• Introduction to The Program
• Presentation by Dr. Eichenbaum - Proof-of-Concept (PoC) Study for Candidate Identification in Geographic Atrophy: Potential for Enrollment Efficiency and Enrichment using AI-Driven Workflow
• Faculty Panel Discussion: Why is Recruitment Still So Difficult?
• Presentation by Dr. Javaheri - Understanding the Real-World Phenotypes
• Presentation by Dr. Minaker - From Phenotypes to Endpoints
• Faculty Discussion: Phenotypes, Functional OCT & Endpoints... How do Sponsors Incorporate the Info?
• Presentation by Dr. Sambhara - Connecting A Network
• Faculty Discussion: Final Thoughts on How AI Plays a Role in Pharma Drug Development... Candidate Identification, Phenotypes, Endpoints